A carregar...
Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
Hematological malignancies are important diseases that need more powerful therapeutics. Even with current targeting therapies, such as rituximab and other chemotherapeutic agents, there is a need to develop new treatment strategies. Combination therapy seems the best option to target the tumor cells...
Na minha lista:
| Publicado no: | Oncolytic Virother |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4996254/ https://ncbi.nlm.nih.gov/pubmed/27579294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S95250 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|